KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Total Non-Current Liabilities (2017 - 2025)

Guardant Health (GH) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 29.55% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 29.55% year-over-year, with the annual reading at $2.0 billion for FY2025, 29.55% up from the prior year.
  • Total Non-Current Liabilities hit $2.0 billion in Q4 2025 for Guardant Health, up from $1.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.0 billion in Q4 2025 to a low of $1.4 billion in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 1201.66% in 2021 and later dropped 3.17% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $1.6 billion in 2021, then dropped by 0.96% to $1.5 billion in 2022, then fell by 0.58% to $1.5 billion in 2023, then increased by 0.05% to $1.5 billion in 2024, then rose by 29.55% to $2.0 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for GH at $2.0 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.